Agile Therapeutics reported $26.12M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Aceto ACET:US 208.73M 12.94M
Adma Biologics ADMA:US $ 42.41M 19.56M
Agile Therapeutics AGRX:US $ 26.12M 9.65M
Antares Pharma ATRS:US $ 45.13M 10.53M
Bayer BAYN:GR € 3389M 2161M
Biodelivery Sciences International BDSI:US 119.85M 3.42M
Biomarin Pharmaceutical BMRN:US $ 641.53M 25.78M
Pacira Pharmaceuticals PCRX:US $ 105.77M 39.08M
Pain Therapeutics PTIE:US $ 278.25M 3.94M
Teva Pharmaceutical Industries TEVA:US $ 2436M 693M